Myocardial substrate metabolism in heart disease

Frontiers in Bioscience - Scholar

Volumn 4 S, Issue 2, 2012, Pages 556-580

  Evans, Rhys D ^a   Clarke, Kieran ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Disease; Heart; Metabolism; Review

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DICHLOROACETIC ACID; ETOMOXIR; FIBRIC ACID DERIVATIVE; INSULIN; NICOTINIC ACID; OXFENICINE; PERHEXILINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; RANOLAZINE; TRIMETAZIDINE; FATTY ACID; GLUCOSE;

ARTICLE; DIABETES MELLITUS; ENERGY METABOLISM; FETUS HEART; HEART DISEASE; HEART FAILURE; HEART MUSCLE METABOLISM; HEART VENTRICLE HYPERTROPHY; HUMAN; NONHUMAN; REPERFUSION INJURY; ANIMAL; HEART; HEART MUSCLE; METABOLISM; PATHOPHYSIOLOGY; REVIEW;

ANIMALS; ENERGY METABOLISM; FATTY ACIDS; GLUCOSE; HEART; HEART DISEASES; HUMANS; MYOCARDIUM;

EID: 84869382852     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/s285     Document Type: Article

References (322)

1. G. D. Lopaschuk, D. D. Belke, J. Gamble, T. Itoi and B. O. Schonekess: Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochimica et Biophysica Acta, 1213(3), 263-76 (1994) (Pubitemid 24262910)
2. G. D. Lopaschuk, J. R. Ussher, C. D. L. Folmes, J. S. Jaswal and W. C. Stanley: Myocardial fatty acid metabolism in health and disease. Physiological Reviews, 90(1), 207-58 (2010)
3. L. H. Opie: Metabolism of the heart in health and disease. I. American Heart Journal, 76(5), 685-98 (1968)
4. L. H. Opie: Metabolism of the heart in health and disease. II. American Heart Journal, 77(1), 100-22 contd (1969)
5. J. R. Neely and H. E. Morgan: Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annual Review of Physiology, 36, 413-59 (1974)
6. W. C. Stanley, G. D. Lopaschuk, J. L. Hall and J. G. McCormack: Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovascular Research, 33(2), 243-57 (1997) (Pubitemid 27072627)
7. G. J. van der Vusse, J. F. Glatz, H. C. Stam and R. S. Reneman: Fatty acid homeostasis in the normoxic and ischemic heart. Physiological Reviews, 72(4), 881-940 (1992)
8. W. C. Stanley, F. A. Recchia and G. D. Lopaschuk: Myocardial substrate metabolism in the normal and failing heart. Physiological Reviews, 85(3), 1093-129 (2005) (Pubitemid 40894649)
9. R. Ventura-Clapier, A. Garnier and V. Veksler: Energy metabolism in heart failure. Journal of Physiology, 555(Pt 1), 1-13 (2004) (Pubitemid 38313058)
10. S. Neubauer: The failing heart-an engine out of fuel. New England Journal of Medicine, 356(11), 1140-51 (2007) (Pubitemid 46425598)
11. J. A. Wisneski, E. W. Gertz, R. A. Neese, L. D. Gruenke, D. L. Morris and J. C. Craig: Metabolic fate of extracted glucose in normal human myocardium. Journal of Clinical Investigation, 76(5), 1819-27 (1985) (Pubitemid 16196050)
12. J. A. Wisneski, W. C. Stanley, R. A. Neese and E. W. Gertz: Effects of acute hyperglycemia on myocardial glycolytic activity in humans. Journal of Clinical Investigation, 85(5), 1648-56 (1990) (Pubitemid 20176463)
13. H. Taegtmeyer, M. E. Harinstein and M. Gheorghiade: More than bricks and mortar: comments on protein and amino acid metabolism in the heart. American Journal of Cardiology, 101(11A), 3E-7E (2008)
14. H. Taegtmeyer, C. R. Wilson, P. Razeghi and S. Sharma: Metabolic energetics and genetics in the heart. Annals of the New York Academy of Sciences, 1047, 208-18 (2005) (Pubitemid 41123841)
15. H. Taegtmeyer, P. McNulty and M. E. Young: Adaptation and maladaptation of the heart in diabetes: Part I: general concepts. Circulation, 105(14), 1727-33 (2002) (Pubitemid 34298619)
16. M. E. Young, P. McNulty and H. Taegtmeyer: Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms. Circulation, 105(15), 1861-70 (2002) (Pubitemid 34408899)
17. B. A. Cason, J. A. Wisneski, R. A. Neese, W. C. Stanley, R. F. Hickey, C. B. Shnier and E. W. Gertz: Effects of high arterial oxygen tension on function, blood flow distribution, and metabolism in ischemic myocardium. Circulation, 85(2), 828-38 (1992)
18. G. J. van der Vusse, M. van Bilsen, J. F. Glatz, D. M. Hasselbaink and J. J. Luiken: Critical steps in cellular fatty acid uptake and utilization. Molecular & Cellular Biochemistry, 239(1-2), 9-15 (2002) (Pubitemid 35385790)
19. A. Bonen, A. Chabowski, J. J. Luiken and J. F. Glatz: Is membrane transport of FFA mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical, and physiological evidence.[comment]. Physiology, 22, 15-29 (2007)
20. G. J. van der Vusse, M. van Bilsen and J. F. Glatz: Cardiac fatty acid uptake and transport in health and disease. Cardiovascular Research, 45(2), 279-93 (2000) (Pubitemid 30069493)
21. D. Hauton, M. J. Bennett and R. D. Evans: Utilisation of triacylglycerol and non-esterified fatty acid by the working rat heart: myocardial lipid substrate preference. Biochimica et Biophysica Acta, 1533(2), 99-109 (2001) (Pubitemid 32879386)
22. A. S. Neitzel, A. N. Carley and D. L. Severson: Chylomicron and palmitate metabolism by perfused hearts from diabetic mice. American Journal of Physiology - Endocrinology & Metabolism, 284(2), E357-65 (2003) (Pubitemid 36120109)
23. N. Sambandam, M. A. Abrahani, S. Craig, O. Al-Atar, E. Jeon and B. Rodrigues: Metabolism of VLDL is increased in streptozotocin-induced diabetic rat hearts. American Journal of Physiology - Heart & Circulatory Physiology, 278(6), H1874-82 (2000) (Pubitemid 30439199)
24. A. S. Augustus, Y. Kako, H. Yagyu and I. J. Goldberg: Routes of FA delivery to cardiac muscle: modulation of lipoprotein lipolysis alters uptake of TG-derived FA. American Journal of Physiology - Endocrinology & Metabolism, 284(2), E331-9 (2003) (Pubitemid 36120106)
25. H.-L. Noh, H. Yamashita and I. J. Goldberg: Cardiac metabolism and mechanics are altered by genetic loss of lipoprotein triglyceride lipolysis. Cardiovascular Drugs & Therapy, 20(6), 441-4 (2006) (Pubitemid 46144221)
26. J. Lee and I. J. Goldberg: Lipoprotein lipase-derived fatty acids: physiology and dysfunction. Current Hypertension Reports, 9(6), 462-6 (2007)
27. M. Merkel, R. H. Eckel and I. J. Goldberg: Lipoprotein lipase: genetics, lipid uptake, and regulation. Journal of Lipid Research, 43(12), 1997-2006 (2002) (Pubitemid 35471065)
28. H. Wang and R. H. Eckel: Lipoprotein lipase: from gene to obesity. American Journal of Physiology - Endocrinology & Metabolism, 297(2), E271-88 (2009)
29. T. Pulinilkunnil and B. Rodrigues: Cardiac lipoprotein lipase: metabolic basis for diabetic heart disease. Cardiovascular Research, 69(2), 329-40 (2006) (Pubitemid 43098789)
30. I. J. Goldberg and M. Merkel: Lipoprotein lipase: physiology, biochemistry, and molecular biology. Frontiers in Bioscience, 6, D388-405 (2001)
31. S. Takahashi, J. Sakai, T. Fujino, H. Hattori, Y. Zenimaru, J. Suzuki, I. Miyamori and T. T. Yamamoto: The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor. Journal of Atherosclerosis & Thrombosis, 11(4), 200-8 (2004)
32. S. Takahashi, J. Sakai, T. Fujino, I. Miyamori and T. T. Yamamoto: The very low density lipoprotein (VLDL) receptor-a peripheral lipoprotein receptor for remnant lipoproteins into fatty acid active tissues. Molecular & Cellular Biochemistry, 248(1-2), 121-7 (2003) (Pubitemid 36833649)
33. B. Teusink, P. J. Voshol, V. E. Dahlmans, P. C. Rensen, H. Pijl, J. A. Romijn and L. M. Havekes: Contribution of fatty acids released from lipolysis of plasma triglycerides to total plasma fatty acid flux and tissue-specific fatty acid uptake. Diabetes, 52(3), 614-20 (2003) (Pubitemid 36323566)
34. I. J. Goldberg, R. H. Eckel and N. A. Abumrad: Regulation of fatty acid uptake into tissues: lipoprotein lipase-and CD36-mediated pathways. Journal of Lipid Research, 50 Suppl, S86-90 (2009)
35. Y. G. Niu, D. Hauton and R. D. Evans: Utilization of triacylglycerol-rich lipoproteins by the working rat heart: routes of uptake and metabolic fates. Journal of Physiology, 558(Pt 1), 225-37 (2004) (Pubitemid 39077403)
36. T. S. Park, H. Yamashita, W. S. Blaner and I. J. Goldberg: Lipids in the heart: a source of fuel and a source of toxins. Current Opinion in Lipidology, 18(3), 277-82 (2007) (Pubitemid 46743051)
37. M. Saddik and G. D. Lopaschuk: Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. Journal of Biological Chemistry, 266(13), 8162-70 (1991) (Pubitemid 21906491)
38. H. L. Noh, K. Okajima, J. D. Molkentin, S. Homma and I. J. Goldberg: Acute lipoprotein lipase deletion in adult mice leads to dyslipidemia and cardiac dysfunction. [erratum appears in Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E367 Note: Homma, Sunichi [corrected to Homma, Shunichi]]. American Journal of Physiology - Endocrinology & Metabolism, 291(4), E755-60 (2006)
39. A. S. Augustus, J. Buchanan, T. S. Park, K. Hirata, H. L. Noh, J. Sun, S. Homma, J. D'Armiento, E. D. Abel and I. J. Goldberg: Loss of lipoprotein lipase-derived fatty acids leads to increased cardiac glucose metabolism and heart dysfunction. Journal of Biological Chemistry, 281(13), 8716-23 (2006) (Pubitemid 43847976)
40. A. Augustus, H. Yagyu, G. Haemmerle, A. Bensadoun, R. K. Vikramadithyan, S. Y. Park, J. K. Kim, R. Zechner and I. J. Goldberg: Cardiac-specific knock-out of lipoprotein lipase alters plasma lipoprotein triglyceride metabolism and cardiac gene expression. Journal of Biological Chemistry, 279(24), 25050-7 (2004) (Pubitemid 38756753)
41. R. G. Forsey, K. Reid and J. T. Brosnan: Competition between fatty acids and carbohydrate or ketone bodies as metabolic fuels for the isolated perfused heart. Canadian Journal of Physiology & Pharmacology, 65(3), 401-6 (1987) (Pubitemid 17068315)
42. D. M. Hasselbaink, J. F. Glatz, J. J. Luiken, T. H. Roemen and G. J. Van der Vusse: Ketone bodies disturb fatty acid handling in isolated cardiomyocytes derived from control and diabetic rats. Biochemical Journal, 371(Pt 3), 753-60 (2003) (Pubitemid 36578874)
43. H. Taegtmeyer, R. Hems and H. A. Krebs: Utilization of energy-providing substrates in the isolated working rat heart. Biochemical Journal, 186(3), 701-11 (1980) (Pubitemid 10113089)
44. M. G. Buse, J. F. Biggers, C. Drier and J. F. Buse: The effect of epinephrine, glucagon, and the nutritional state on the oxidation of branched chain amino acids and pyruvate by isolated hearts and diaphragms of the rat. Journal of Biological Chemistry, 248(2), 697-706 (1973)
45. M. L. Brennan and S. L. Hazen: Amino acid and protein oxidation in cardiovascular disease. Amino Acids, 25(3-4), 365-74 (2003) (Pubitemid 38041272)
46. F. L. Shinnick and A. E. Harper: Branched-chain amino acid oxidation by isolated rat tissue preparations. Biochimica et Biophysica Acta, 437(2), 477-86 (1976)
47. M. E. Tischler and H. Cammisa: Metabolism of protein, amino acids, and glucose and their response to insulin in atria and cardiac myocytes of traumatized rats. Metabolism: Clinical & Experimental, 33(6), 515-20 (1984) (Pubitemid 14119896)
48. J. Letto, J. T. Brosnan and M. E. Brosnan: Oxidation of 2-oxoisocaproate and 2-oxoisovalerate by the perfused rat heart. Interactions with fatty acid oxidation. Biochemistry & Cell Biology, 68(1), 260-5 (1990) (Pubitemid 20259671)
49. C. Carson and G. V. Vahouny: Myocardial metabolism. V. Effect of puromycin on protein synthesis and oxidation of glucose, acetate, and aspartate in perfused rat hearts. Proceedings of the Society for Experimental Biology & Medicine, 132(1), 287-92 (1969)
50. I. F. Kodde, J. van der Stok, R. T. Smolenski and J. W. de Jong: Metabolic and genetic regulation of cardiac energy substrate preference. Comparative Biochemistry & Physiology. Part A, Molecular & Integrative Physiology, 146(1), 26-39 (2007) (Pubitemid 46186082)
51. H. Tapiero, G. Mathe, P. Couvreur and K. D. Tew: I. Arginine. Biomedicine & Pharmacotherapy, 56(9), 439-45 (2002)
52. S. L. Menard, E. Croteau, O. Sarrhini, R. Gelinas, P. Brassard, R. Ouellet, M. Bentourkia, J. E. van Lier, C. Des Rosiers, R. Lecomte and A. C. Carpentier: Abnormal in vivo myocardial energy substrate uptake in diet-induced type 2 diabetic cardiomyopathy in rats. American Journal of Physiology - Endocrinology & Metabolism, 298(5), E1049-57 (2010)
53. J. Girard, P. Ferre, J. P. Pegorier and P. H. Duee: Adaptations of glucose and fatty acid metabolism during perinatal period and suckling-weaning transition. Physiological Reviews, 72(2), 507-62 (1992)
54. P. Haggarty: Fatty acid supply to the human fetus. Annual Review of Nutrition, 30, 237-55 (2010)
55. E. Herrera: Lipid metabolism in pregnancy and its consequences in the fetus and newborn. Endocrine, 19(1), 43-55 (2002) (Pubitemid 36106251)
56. D. J. Fisher, M. A. Heymann and A. M. Rudolph: Myocardial oxygen and carbohydrate consumption in fetal lambs in utero and in adult sheep. American Journal of Physiology, 238(3), H399-405 (1980) (Pubitemid 10118496)
57. G. D. Lopaschuk, M. A. Spafford and D. R. Marsh: Glycolysis is predominant source of myocardial ATP production immediately after birth. American Journal of Physiology, 261(6 Pt 2), H1698-705 (1991)
58. G. D. Lopaschuk, R. L. Collins-Nakai and T. Itoi: Developmental changes in energy substrate use by the heart. Cardiovascular Research, 26(12), 1172-80 (1992) (Pubitemid 23010529)
59. T. P. Rolph and C. T. Jones: Glucose metabolism in the perfused heart of the foetal guinea pig. Biochemical Society Transactions, 9(1), 65 (1981)
60. T. P. Rolph and C. T. Jones: Regulation of glycolytic flux in the heart of the fetal guinea pig. Journal of Developmental Physiology, 5(1), 31-49 (1983) (Pubitemid 13108360)
61. C. T. Jones and T. P. Rolph: Metabolism during fetal life: a functional assessment of metabolic development. Physiological Reviews, 65(2), 357-430 (1985) (Pubitemid 15081128)
62. J. C. Werner and R. E. Sicard: Lactate metabolism of isolated, perfused fetal, and newborn pig hearts. Pediatric Research, 22(5), 552-6 (1987) (Pubitemid 18002062)
63. J. C. Werner, R. E. Sicard and H. G. Schuler: Palmitate oxidation by isolated working fetal and newborn pig hearts. American Journal of Physiology, 256(2 Pt 1), E315-21 (1989)
64. C. Depre, P. J. Davies and H. Taegtmeyer: Transcriptional adaptation of the heart to mechanical unloading. American Journal of Cardiology, 83(12A), 58H-63H (1999) (Pubitemid 29330930)
65. C. Depre, G. L. Shipley, W. Chen, Q. Han, T. Doenst, M. L. Moore, S. Stepkowski, P. J. Davies and H. Taegtmeyer: Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nature Medicine, 4(11), 1269-75 (1998) (Pubitemid 28512107)
66. J. J. Lehman and D. P. Kelly: Transcriptional activation of energy metabolic switches in the developing and hypertrophied heart. Clinical & Experimental Pharmacology & Physiology, 29(4), 339-45 (2002) (Pubitemid 34227071)
67. A. Onay-Besikci: Regulation of cardiac energy metabolism in newborn. Molecular & Cellular Biochemistry, 287(1-2), 1-11 (2006) (Pubitemid 44057387)
68. M. A. Yatscoff, J. S. Jaswal, M. R. Grant, R. Greenwood, T. Lukat, D. L. Beker, I. M. Rebeyka and G. D. Lopaschuk: Myocardial hypertrophy and the maturation of fatty acid oxidation in the newborn human heart. Pediatric Research, 64(6), 643-7 (2008)
69. G. W. Goodwin, C. S. Taylor and H. Taegtmeyer: Regulation of energy metabolism of the heart during acute increase in heart work. Journal of Biological Chemistry, 273(45), 29530-9 (1998) (Pubitemid 28509960)
70. A. S. Most, N. Brachfeld, R. Gorlin and J. Wahren: Free fatty acid metabolism of the human heart at rest. Journal of Clinical Investigation, 48(7), 1177-88 (1969)
71. C. Montessuit, I. Papageorgiou, I. Tardy and R. Lerch: Effect of nutritional state on substrate metabolism and contractile function in postischemic rat myocardium. American Journal of Physiology, 271(5 Pt 2), H2060-70 (1996)
72. P. J. Randle, P. B. Garland, C. N. Hales and E. A. Newsholme: The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet, 1, 785-9 (1963)
73. X. Wang, D. G. Hole, T. H. Da Costa and R. D. Evans: Alterations in myocardial lipid metabolism during lactation in the rat. American Journal of Physiology, 275(2 Pt 1), E265-71 (1998)
74. W. C. Stanley and M. P. Chandler: Energy metabolism in the normal and failing heart: potential for therapeutic interventions. Heart Failure Reviews, 7(2), 115-30 (2002) (Pubitemid 34624800)
75. O. D. Mjos: Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs. Journal of Clinical Investigation, 50(7), 1386-9 (1971)
76. O. D. Mjos, J. K. Kjekshus and J. Lekven: Importance of free fatty acids as a determinant of myocardial oxygen consumption and myocardial ischemic injury during norepinephrine infusion in dogs. Journal of Clinical Investigation, 53(5), 1290-9 (1974)
77. D. F. Rolfe, A. J. Hulbert and M. D. Brand: Characteristics of mitochondrial proton leak and control of oxidative phosphorylation in the major oxygen-consuming tissues of the rat. Biochimica et Biophysica Acta, 1188(3), 405-16 (1994)
78. P. Wang, S. G. Lloyd and J. C. Chatham: Impact of high glucose/high insulin and dichloroacetate treatment on carbohydrate oxidation and functional recovery after lowflow ischemia and reperfusion in the isolated perfused rat heart. Circulation, 111(16), 2066-72 (2005) (Pubitemid 40577901)
79. I. Luptak, J. Yan, L. Cui, M. Jain, R. Liao and R. Tian: Long-term effects of increased glucose entry on mouse hearts during normal aging and ischemic stress. Circulation, 116(8), 901-9 (2007) (Pubitemid 47300914)
80. C. J. Zuurbier, J. van Dijk, N. G. Abeling, J. C. M. Meijers, J. H. M. Levels, E. de Jonge, B. A. de Mol and H. B. van Wezel: A perioperative hyperinsulinaemic normoglycaemic clamp causes hypolipidaemia after coronary artery surgery. British Journal of Anaesthesia (2008)
81. B. Comte, G. Vincent, B. Bouchard, M. Jette, S. Cordeau and C. D. Rosiers: A 13C mass isotopomer study of anaplerotic pyruvate carboxylation in perfused rat hearts. Journal of Biological Chemistry, 272(42), 26125-31 (1997) (Pubitemid 27458819)
82. M. J. Gibala, M. E. Young and H. Taegtmeyer: Anaplerosis of the citric acid cycle: role in energy metabolism of heart and skeletal muscle. Acta Physiologica Scandinavica, 168(4), 657-65 (2000) (Pubitemid 30197902)
83. N. Sorokina, J. M. O'Donnell, R. D. McKinney, K. M. Pound, G. Woldegiorgis, K. F. LaNoue, K. Ballal, H. Taegtmeyer, P. M. Buttrick and E. D. Lewandowski: Recruitment of compensatory pathways to sustain oxidative flux with reduced carnitine palmitoyltransferase I activity characterizes inefficiency in energy metabolism in hypertrophied hearts. Circulation, 115(15), 2033-41 (2007) (Pubitemid 46625954)
84. J. A. Kline, L. R. Thornton, G. D. Lopaschuk, R. W. Barbee and J. A. Watts: Lactate improves cardiac efficiency after hemorrhagic shock. Shock, 14(2), 215-21 (2000)
85. R. R. Russell, 3rd and H. Taegtmeyer: Changes in citric acid cycle flux and anaplerosis antedate the functional decline in isolated rat hearts utilizing acetoacetate. Journal of Clinical Investigation, 87(2), 384-90 (1991)
86. R. R. Russell, 3rd and H. Taegtmeyer: Pyruvate carboxylation prevents the decline in contractile function of rat hearts oxidizing acetoacetate. American Journal of Physiology, 261(6 Pt 2), H1756-62 (1991)
87. S. Gupta, B. Das and S. Sen: Cardiac hypertrophy: mechanisms and therapeutic opportunities. Antioxidants & Redox Signaling, 9(6), 623-52 (2007) (Pubitemid 46799096)
88. M. F. Allard: Energy substrate metabolism in cardiac hypertrophy. Current Hypertension Reports, 6(6), 430-5 (2004) (Pubitemid 39600098)
89. J. Zhang: Myocardial energetics in cardiac hypertrophy. Clinical & Experimental Pharmacology & Physiology, 29(4), 351-9 (2002) (Pubitemid 34227073)
90. Y. C. Zhu, Y. Z. Zhu, H. Spitznagel, P. Gohlke and T. Unger: Substrate metabolism, hormone interaction, and angiotensin-converting enzyme inhibitors in left ventricular hypertrophy. Diabetes, 45 Suppl 1, S59-65 (1996) (Pubitemid 26011991)
91. H. S. Leong, R. W. Brownsey, J. E. Kulpa and M. F. Allard: Glycolysis and pyruvate oxidation in cardiac hypertrophy-why so unbalanced? Comparative Biochemistry & Physiology. Part A, Molecular & Integrative Physiology, 135(4), 499-513 (2003) (Pubitemid 37289111)
92. S. Rimbaud, H. Sanchez, A. Garnier, D. Fortin, X. Bigard, V. Veksler and R. Ventura-Clapier: Stimulus specific changes of energy metabolism in hypertrophied heart. Journal of Molecular & Cellular Cardiology, 46(6), 952-9 (2009)
93. N. Sambandam, G. D. Lopaschuk, R. W. Brownsey and M. F. Allard: Energy metabolism in the hypertrophied heart. Heart Failure Reviews, 7(2), 161-73 (2002) (Pubitemid 34624804)
94. N. D. Vaziri, K. Liang and C. H. Barton: Effect of increased afterload on cardiac lipoprotein lipase and VLDL receptor expression. Biochimica et Biophysica Acta, 1436(3), 577-84 (1999) (Pubitemid 29242937)
95. H. Taegtmeyer: Genetics of energetics: transcriptional responses in cardiac metabolism. Annals of Biomedical Engineering, 28(8), 871-6 (2000) (Pubitemid 32085371)
96. Y. Burelle, R. B. Wambolt, M. Grist, H. L. Parsons, J. C. Chow, C. Antler, A. Bonen, A. Keller, G. A. Dunaway, K. M. Popov, P. W. Hochachka and M. F. Allard: Regular exercise is associated with a protective metabolic phenotype in the rat heart. American Journal of Physiology - Heart & Circulatory Physiology, 287(3), H1055-63 (2004) (Pubitemid 39096650)
97. S. C. Dennis, W. Gevers and L. H. Opie: Protons in ischemia: where do they come from; where do they go to? Journal of Molecular & Cellular Cardiology, 23(9), 1077-86 (1991)
98. E. W. Gertz, J. A. Wisneski, W. C. Stanley and R. A. Neese: Myocardial substrate utilization during exercise in humans. Dual carbon-labeled carbohydrate isotope experiments. Journal of Clinical Investigation, 82(6), 2017-25 (1988) (Pubitemid 19054950)
99. B. W. Lassers, L. Kaijser, M. L. Wahlqvist and L. A. Carlson: Relationship in man between plasma free fatty acids and myocardial metabolism of carbohydrate substrates. Lancet, 2(7722), 448-50 (1971)
100. L. Kaijser, B. W. Lassers, M. L. Wahlqvist and L. A. Carlson: Myocardial lipid and carbohydrate metabolism in fasting men during prolonged exercise. Journal of Applied Physiology, 32(6), 847-58 (1972)
101. G. W. Goodwin and H. Taegtmeyer: Improved energy homeostasis of the heart in the metabolic state of exercise. American Journal of Physiology - Heart & Circulatory Physiology, 279(4), H1490-501 (2000)
102. N. Sharma, I. C. Okere, D. Z. Brunengraber, T. A. McElfresh, K. L. King, J. P. Sterk, H. Huang, M. P. Chandler and W. C. Stanley: Regulation of pyruvate dehydrogenase activity and citric acid cycle intermediates during high cardiac power generation. Journal of Physiology, 562(Pt 2), 593-603 (2005)
103. L. Zhou, H. Huang, C. L. Yuan, W. Keung, G. D. Lopaschuk and W. C. Stanley: Metabolic response to an acute jump in cardiac workload: effects on malonyl-CoA, mechanical efficiency, and fatty acid oxidation. American Journal of Physiology - Heart & Circulatory Physiology, 294(2), H954-60 (2008) (Pubitemid 351253308)
104. L. Zhou, M. E. Cabrera, H. Huang, C. L. Yuan, D. K. Monika, N. Sharma, F. Bian and W. C. Stanley: Parallel activation of mitochondrial oxidative metabolism with increased cardiac energy expenditure is not dependent on fatty acid oxidation in pigs. Journal of Physiology, 579(Pt 3), 811-21 (2007) (Pubitemid 46404361)
105. P. Razeghi, M. E. Young, J. L. Alcorn, C. S. Moravec, O. H. Frazier and H. Taegtmeyer: Metabolic gene expression in fetal and failing human heart. Circulation, 104(24), 2923-31 (2001) (Pubitemid 33139104)
106. J. J. Lehman and D. P. Kelly: Gene regulatory mechanisms governing energy metabolism during cardiac hypertrophic growth. Heart Failure Reviews, 7(2), 175-85 (2002) (Pubitemid 34624805)
107. M. F. Allard, B. O. Schonekess, S. L. Henning, D. R. English and G. D. Lopaschuk: Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. American Journal of Physiology, 267(2 Pt 2), H742-50 (1994) (Pubitemid 24272494)
108. Z. el Alaoui-Talibi, S. Landormy, A. Loireau and J. Moravec: Fatty acid oxidation and mechanical performance of volume-overloaded rat hearts. American Journal of Physiology, 262(4 Pt 2), H1068-74 (1992)
109. G. Vincent, M. Khairallah, B. Bouchard, C. Des Rosiers, G. Vincent, M. Khairallah, B. Bouchard and C. Des Rosiers: Metabolic phenotyping of the diseased rat heart using 13C-substrates and ex vivo perfusion in the working mode. Molecular & Cellular Biochemistry, 242(1-2), 89-99 (2003) (Pubitemid 36240533)
110. F. Labarthe, R. Gelinas and C. Des Rosiers: Mediumchain fatty acids as metabolic therapy in cardiac disease. Cardiovascular Drugs & Therapy, 22(2), 97-106 (2008)
111. P. M. Barger and D. P. Kelly: Fatty acid utilization in the hypertrophied and failing heart: molecular regulatory mechanisms. American Journal of the Medical Sciences, 318(1), 36-42 (1999) (Pubitemid 30387273)
112. B. Guertl, C. Noehammer and G. Hoefler: Metabolic cardiomyopathies. International Journal of Experimental Pathology, 81(6), 349-72 (2000) (Pubitemid 32291178)
113. C. Amat di San Filippo, M. R. Taylor, L. Mestroni, L. D. Botto and N. Longo: Cardiomyopathy and carnitine deficiency. Molecular Genetics & Metabolism, 94(2), 162-6 (2008)
114. E. Fosslien: Review: Mitochondrial medicine-cardiomyopathy caused by defective oxidative phosphorylation. Annals of Clinical & Laboratory Science, 33(4), 371-95 (2003) (Pubitemid 37288648)
115. T. Hajri, A. Ibrahimi, C. T. Coburn, F. F. Knapp, Jr., T. Kurtz, M. Pravenec and N. A. Abumrad: Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia, and myocardial hypertrophy. Journal of Biological Chemistry, 276(26), 23661-6 (2001)
116. T. Tanaka, K. Sohmiya and K. Kawamura: Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? Journal of Molecular & Cellular Cardiology, 29(1), 121-7 (1997) (Pubitemid 27129136)
117. G. Paolisso, A. Gambardella, D. Galzerano, A. D'Amore, P. Rubino, M. Verza, P. Teasuro, M. Varricchio and F. D'Onofrio: Total-body and myocardial substrate oxidation in congestive heart failure. Metabolism: Clinical & Experimental, 43(2), 174-9 (1994) (Pubitemid 24061849)
118. J. Lommi, M. Kupari and H. Yki-Jarvinen: Free fatty acid kinetics and oxidation in congestive heart failure. American Journal of Cardiology, 81(1), 45-50 (1998) (Pubitemid 28046841)
119. A. J. Murray, C. A. Lygate, M. A. Cole, C. A. Carr, G. K. Radda, S. Neubauer and K. Clarke: Insulin resistance, abnormal energy metabolism and increased ischemic damage in the chronically infarcted rat heart. Cardiovascular Research, 71(1), 149-57 (2006) (Pubitemid 43849666)
120. H. Ashrafian, M. P. Frenneaux and L. H. Opie: Metabolic mechanisms in heart failure. Circulation, 116(4), 434-48 (2007) (Pubitemid 47196549)
121. H. Tuunanen, H. Ukkonen and J. Knuuti: Myocardial fatty acid metabolism and cardiac performance in heart failure. Current Cardiology Reports, 10(2), 142-8 (2008)
122. J. A. Wisneski, E. W. Gertz, R. A. Neese and M. Mayr: Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans. Journal of Clinical Investigation, 79(2), 359-66 (1987) (Pubitemid 17009666)
123. D. Neglia, A. De Caterina, P. Marraccini, A. Natali, M. Ciardetti, C. Vecoli, A. Gastaldelli, D. Ciociaro, P. Pellegrini, R. Testa, L. Menichetti, A. L'Abbate, W. C. Stanley and F. A. Recchia: Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. American Journal of Physiology - Heart & Circulatory Physiology, 293(6), H3270-8 (2007) (Pubitemid 350230867)
124. V. G. Davila-Roman, G. Vedala, P. Herrero, L. de las Fuentes, J. G. Rogers, D. P. Kelly and R. J. Gropler: Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. Journal of the American College of Cardiology, 40(2), 271-7 (2002) (Pubitemid 34756287)
125. J. C. Osorio, W. C. Stanley, A. Linke, M. Castellari, Q. N. Diep, A. R. Panchal, T. H. Hintze, G. D. Lopaschuk and F. A. Recchia: Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure. Circulation, 106(5), 606-12 (2002) (Pubitemid 34827712)
126. L. C. Heather, M. A. Cole, C. A. Lygate, R. D. Evans, D. J. Stuckey, A. J. Murray, S. Neubauer and K. Clarke: Fatty acid transporter levels and palmitate oxidation rate correlate with ejection fraction in the infarcted rat heart. Cardiovascular Research, 72(3), 430-7 (2006) (Pubitemid 44665850)
127. B. Christian, Z. El Alaoui-Talibi, M. Moravec and J. Moravec: Palmitate oxidation by the mitochondria from volume-overloaded rat hearts. Molecular & Cellular Biochemistry, 180(1-2), 117-28 (1998) (Pubitemid 28118811)
128. K. Qanud, M. Mamdani, M. Pepe, R. J. Khairallah, J. Gravel, B. Lei, S. A. Gupte, V. G. Sharov, H. N. Sabbah, W. C. Stanley and F. A. Recchia: Reverse changes in cardiac substrate oxidation in dogs recovering from heart failure. American Journal of Physiology - Heart & Circulatory Physiology, 295(5), H2098-105 (2008)
129. M. P. Chandler, J. Kerner, H. Huang, E. Vazquez, A. Reszko, W. Z. Martini, C. L. Hoppel, M. Imai, S. Rastogi, H. N. Sabbah and W. C. Stanley: Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation. American Journal of Physiology - Heart & Circulatory Physiology, 287(4), H1538-43 (2004) (Pubitemid 39313257)
130. A. Remondino, N. Rosenblatt-Velin, C. Montessuit, I. Tardy, I. Papageorgiou, P. A. Dorsaz, M. Jorge-Costa and R. Lerch: Altered expression of proteins of metabolic regulation during remodeling of the left ventricle after myocardial infarction. Journal of Molecular & Cellular Cardiology, 32(11), 2025-34 (2000)
131. J. Lommi, P. Koskinen, H. Naveri, M. Harkonen and M. Kupari: Heart failure ketosis. Journal of Internal Medicine, 242(3), 231-8 (1997) (Pubitemid 27400436)
132. M. N. Sack, T. A. Rader, S. Park, J. Bastin, S. A. McCune and D. P. Kelly: Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation, 94(11), 2837-42 (1996) (Pubitemid 26411749)
133. P. M. Barger and D. P. Kelly: PPAR signaling in the control of cardiac energy metabolism. Trends in Cardiovascular Medicine, 10(6), 238-45 (2000) (Pubitemid 32229879)
134. J. A. Madrazo and D. P. Kelly: The PPAR trio: regulators of myocardial energy metabolism in health and disease. Journal of Molecular & Cellular Cardiology, 44(6), 968-75 (2008)
135. M. G. Rosca, E. J. Vazquez, J. Kerner, W. Parland, M. P. Chandler, W. Stanley, H. N. Sabbah and C. L. Hoppel: Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation. Cardiovascular Research, 80(1), 30-9 (2008)
136. L. C. Heather, C. A. Carr, D. J. Stuckey, S. Pope, K. J. Morten, E. E. Carter, L. M. Edwards and K. Clarke: Critical role of complex III in the early metabolic changes following myocardial infarction. Cardiovascular Research, 85(1), 127-36 (2010)
137. S. Neubauer, M. Horn, A. Naumann, R. Tian, K. Hu, M. Laser, J. Friedrich, P. Gaudron, K. Schnackerz, J. S. Ingwall and G. Ertl: Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction. Journal of Clinical Investigation, 95(3), 1092-100 (1995)
138. J. M. Huss and D. P. Kelly: Nuclear receptor signaling and cardiac energetics. Circulation Research, 95(6), 568-78 (2004) (Pubitemid 39274371)
139. G. D. Lopaschuk and D. P. Kelly: Signalling in cardiac metabolism. Cardiovascular Research, 79(2), 205-7 (2008) (Pubitemid 351951619)
140. J. M. Huss and D. P. Kelly: Mitochondrial energy metabolism in heart failure: a question of balance. Journal of Clinical Investigation, 115(3), 547-55 (2005) (Pubitemid 40322224)
141. J. S. Ingwall, D. E. Atkinson, K. Clarke and J. K. Fetters: Energetic correlates of cardiac failure: changes in the creatine kinase system in the failing myocardium. European Heart Journal, 11 Suppl B, 108-15 (1990) (Pubitemid 20181258)
142. W. Wang and G. D. Lopaschuk: Metabolic therapy for the treatment of ischemic heart disease: reality and expectations. Expert Review of Cardiovascular Therapy, 5(6), 1123-34 (2007) (Pubitemid 350303047)
143. G. D. Lopaschuk and W. C. Stanley: Malonyl-CoA decarboxylase inhibition as a novel approach to treat ischemic heart disease. Cardiovascular Drugs & Therapy, 20(6), 433-9 (2006) (Pubitemid 46144220)
144. G. D. Lopaschuk: Optimizing cardiac fatty acid and glucose metabolism as an approach to treating heart failure. Seminars in Cardiothoracic & Vascular Anesthesia, 10(3), 228-30 (2006) (Pubitemid 44221892)
145. G. D. Lopaschuk: Optimizing cardiac energy metabolism: how can fatty acid and carbohydrate metabolism be manipulated? Coronary Artery Disease, 12 Suppl 1, S8-11 (2001)
146. K. Abozguia, K. Clarke, L. Lee and M. Frenneaux: Modification of myocardial substrate use as a therapy for heart failure. Nature Clinical Practice Cardiovascular Medicine, 3(9), 490-8 (2006) (Pubitemid 44288462)
147. H. Taegtmeyer, L. M. King and B. E. Jones: Energy substrate metabolism, myocardial ischemia, and targets for pharmacotherapy. American Journal of Cardiology, 82(5A), 54K-60K (1998) (Pubitemid 28415355)
148. H. N. Sabbah and W. C. Stanley: Metabolic therapy for heart disease:
149. L. H. Opie and J. Knuuti: The adrenergic-fatty acid load in heart failure. Journal of the American College of Cardiology, 54(18), 1637-46 (2009)
150. B. Lei, V. Lionetti, M. E. Young, M. P. Chandler, C. d'Agostino, E. Kang, M. Altarejos, K. Matsuo, T. H. Hintze, W. C. Stanley and F. A. Recchia: Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure. Journal of Molecular & Cellular Cardiology, 36(4), 567-76 (2004) (Pubitemid 38469947)
151. F. Di Lisa, C. Z. Fan, G. Gambassi, B. A. Hogue, I. Kudryashova and R. G. Hansford: Altered pyruvate dehydrogenase control and mitochondrial free Ca2+ in hearts of cardiomyopathic hamsters. American Journal of Physiology, 264(6 Pt 2), H2188-97 (1993) (Pubitemid 23205993)
152. R. J. Ascuitto and N. T. Ross-Ascuitto: Substrate metabolism in the developing heart. Seminars in Perinatology, 20(6), 542-63 (1996) (Pubitemid 27147001)
153. A. O. Makinde, P. F. Kantor and G. D. Lopaschuk: Maturation of fatty acid and carbohydrate metabolism in the newborn heart. Molecular & Cellular Biochemistry, 188(1-2), 49-56 (1998) (Pubitemid 28493317)
154. G. M. C. Rosano, M. Fini, G. Caminiti and G. Barbaro: Cardiac metabolism in myocardial ischemia. Current Pharmaceutical Design, 14(25), 2551-62 (2008)
155. M. F. Oliver: Control of free fatty acids during acute myocardial ischaemia. Heart, 96(23), 1883-4 (2010)
156. J. R. Neely, M. J. Rovetto, J. T. Whitmer and H. E. Morgan: Effects of ischemia on function and metabolism of the isolated working rat heart. American Journal of Physiology, 225(3), 651-8 (1973)
157. P. H. McNulty, A. J. Sinusas, C. Q. Shi, D. Dione, L. H. Young, G. C. Cline and G. I. Shulman: Glucose metabolism distal to a critical coronary stenosis in a canine model of low-flow myocardial ischemia. Journal of Clinical Investigation, 98(1), 62-9 (1996) (Pubitemid 26243821)
158. S. G. Lloyd, P. Wang, H. Zeng and J. C. Chatham: Impact of low-flow ischemia on substrate oxidation and glycolysis in the isolated perfused rat heart. American Journal of Physiology - Heart & Circulatory Physiology, 287(1), H351-62 (2004) (Pubitemid 38802371)
159. D. J. Paulson, J. J. Noonan, K. M. Ward, H. Stanley, A. Sherratt and A. L. Shug: Effects of POCA on metabolism and function in the ischemic rat heart. Basic Research in Cardiology, 81(2), 180-7 (1986) (Pubitemid 16111893)
160. R. Russell, 3rd: Stress signaling in the heart by AMPactivated protein kinase. Current Hypertension Reports, 8(6), 446-50 (2006) (Pubitemid 44842769)
161. E. Aasum, A. D. Hafstad and T. S. Larsen: Changes in substrate metabolism in isolated mouse hearts following ischemia-reperfusion. Molecular & Cellular Biochemistry, 249(1-2), 97-103 (2003) (Pubitemid 37021035)
162. N. Kudo, A. J. Barr, R. L. Barr, S. Desai and G. D. Lopaschuk: High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5'-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. Journal of Biological Chemistry, 270(29), 17513-20 (1995)
163. N. Kudo, J. G. Gillespie, L. Kung, L. A. Witters, R. Schulz, A. S. Clanachan and G. D. Lopaschuk: Characterization of 5'AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia. Biochimica et Biophysica Acta, 1301(1-2), 67-75 (1996) (Pubitemid 26193063)
164. C. D. Folmes, C. S. Wagg, M. Shen, A. S. Clanachan, R. Tian and G. D. Lopaschuk: Suppression of 5'-AMPactivated protein kinase activity does not impair recovery of contractile function during reperfusion of ischemic hearts. American Journal of Physiology - Heart & Circulatory Physiology, 297(1), H313-21 (2009)
165. T. Pulinilkunnil, P. Puthanveetil, M. S. Kim, F. Wang, V. Schmitt and B. Rodrigues: Ischemia-reperfusion alters cardiac lipoprotein lipase. Biochimica et Biophysica Acta, 1801(2), 171-5 (2010)
166. H. Vik-Mo, P. Moen and O. D. Mjos: Myocardial lipoproteins lipase activity during acute myocardial ischemia in dogs. Hormone & Metabolic Research, 14(2), 85-8 (1982) (Pubitemid 12166844)
167. A. J. Liedtke, S. H. Nellis and O. D. Mjos: Effects of reducing fatty acid metabolism on mechanical function in regionally ischemic hearts. American Journal of Physiology, 247(3 Pt 2), H387-94 (1984) (Pubitemid 14047350)
168. J. K. Kjekshus and O. D. Mjos: Effect of free fatty acids on myocardial function and metabolism in the ischemic dog heart. Journal of Clinical Investigation, 51(7), 1767-76 (1972)
169. K. Clarke, A. J. O'Connor and R. J. Willis: Temporal relation between energy metabolism and myocardial function during ischemia and reperfusion. American Journal of Physiology, 253(2 Pt 2), H412-21 (1987)
170. G. D. Lopaschuk, M. A. Spafford, N. J. Davies and S. R. Wall: Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia. Circulation Research, 66(2), 546-53 (1990) (Pubitemid 20041185)
171. R. H. Benzi and R. Lerch: Dissociation between contractile function and oxidative metabolism in postischemic myocardium. Attenuation by ruthenium red administered during reperfusion. Circulation Research, 71(3), 567-76 (1992)
172. J. B. Michel, A. Nicolletti and J. F. Arnal: Left ventricular remodelling following experimental myocardial infarction. European Heart Journal, 16 Suppl I, 49-57 (1995)
173. J. S. Ingwall: Energy metabolism in heart failure and remodelling. Cardiovascular Research, 81(3), 412-9 (2009)
174. P. Razeghi, T. J. Myers, O. H. Frazier and H. Taegtmeyer: Reverse remodeling of the failing human heart with mechanical unloading. Emerging concepts and unanswered questions. Cardiology, 98(4), 167-74 (2002) (Pubitemid 36091852)
175. Y. Sezai: Progress and future perspectives in mechanical circulatory support. Artificial Organs, 25(5), 318-22 (2001) (Pubitemid 32830457)
176. J. Wang, A. Marui, T. Ikeda and M. Komeda: Partial left ventricular unloading reverses contractile dysfunction and helps recover gene expressions in failing rat hearts. Interactive Cardiovascular & Thoracic Surgery, 7(1), 27-31 (2008) (Pubitemid 351246290)
177. D. Burkhoff, J. W. Holmes, J. Madigan, A. Barbone and M. C. Oz: Left ventricular assist device-induced reverse ventricular remodeling. Progress in Cardiovascular Diseases, 43(1), 19-26 (2000) (Pubitemid 30484565)
178. G. K. R. Soppa, P. J. R. Barton, C. M. N. Terracciano and M. H. Yacoub: Left ventricular assist device-induced molecular changes in the failing myocardium. Current Opinion in Cardiology, 23(3), 206-18 (2008) (Pubitemid 351489323)
179. S. Sharma, J. Ying, P. Razeghi, S. Stepkowski and H. Taegtmeyer: Atrophic remodeling of the transplanted rat heart. Cardiology, 105(2), 128-36 (2006) (Pubitemid 43189789)
180. H. Bugger, S. Leippert, D. Blum, P. Kahle, B. Barleon, D. Marme and T. Doenst: Subtractive hybridization for differential gene expression in mechanically unloaded rat heart. American Journal of Physiology - Heart & Circulatory Physiology, 291(6), H2714-22 (2006) (Pubitemid 44904071)
181. T. Doenst, H. Bugger, S. Leippert, B. Barleon, D. Marme and F. Beyersdorf: Differential gene expression in response to ventricular unloading in rat and human myocardium. Thoracic & Cardiovascular Surgeon, 54(6), 381-7 (2006) (Pubitemid 44519267)
182. T. Doenst, G. W. Goodwin, A. M. Cedars, M. Wang, S. Stepkowski and H. Taegtmeyer: Load-induced changes in vivo alter substrate fluxes and insulin responsiveness of rat heart in vitro. Metabolism: Clinical & Experimental, 50(9), 1083-90 (2001) (Pubitemid 32904169)
183. P. Razeghi, M. E. Young, J. Ying, C. Depre, I. P. Uray, J. Kolesar, G. L. Shipley, C. S. Moravec, P. J. Davies, O. H. Frazier and H. Taegtmeyer: Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading. Cardiology, 97(4), 203-9 (2002)
184. H. Taegtmeyer, P. Razeghi and M. E. Young: Mitochondrial proteins in hypertrophy and atrophy: a transcript analysis in rat heart. Clinical & Experimental Pharmacology & Physiology, 29(4), 346-50 (2002) (Pubitemid 34227072)
185. A. Rodrigue-Way, D. Burkhoff, B. J. Geesaman, S. Golden, J. Xu, M. J. Pollman, M. Donoghue, R. Jeyaseelan, S. Houser, R. E. Breitbart, A. Marks and S. Acton: Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support. Journal of Heart & Lung Transplantation, 24(1), 73-80 (2005) (Pubitemid 40093996)
186. D. Burkhoff, S. Klotz and D. M. Mancini: LVADinduced reverse remodeling: basic and clinical implications for myocardial recovery. Journal of Cardiac Failure, 12(3), 227-39 (2006)
187. T. Takaseya, M. Ishimatsu, E. Tayama, A. Nishi, T. Akasu and S. Aoyagi: Mechanical unloading improves intracellular Ca2+ regulation in rats with doxorubicininduced cardiomyopathy. Journal of the American College of Cardiology, 44(11), 2239-46 (2004) (Pubitemid 39576045)
188. P. M. Heerdt, J. W. Holmes, B. Cai, A. Barbone, J. D. Madigan, S. Reiken, D. L. Lee, M. C. Oz, A. R. Marks and D. Burkhoff: Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation, 102(22), 2713-9 (2000)
189. A. M. Katz: Is the failing heart energy depleted? Cardiology Clinics, 16(4), 633-44, viii (1998) (Pubitemid 28509447)
190. M. N. Sack and D. P. Kelly: The energy substrate switch during development of heart failure: gene regulatory mechanisms (Review). International Journal of Molecular Medicine, 1(1), 17-24 (1998)
191. M. E. Young, F. A. Laws, G. W. Goodwin and H. Taegtmeyer: Reactivation of peroxisome proliferatoractivated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart. Journal of Biological Chemistry, 276(48), 44390-5 (2001)
192. P. Razeghi, M. E. Wang, K. A. Youker, L. Golfman, S. Stepkowski and H. Taegtmeyer: Lack of NF-kappaB1 (p105/p50) attenuates unloading-induced downregulation of PPARalpha and PPARalpha-regulated gene expression in rodent heart. Cardiovascular Research, 74(1), 133-9 (2007) (Pubitemid 46366946)
193. B. B. Ngimbous, F. Bourgeois, C. Mas, M. Simonneau and J. M. Moalic: Heart transplantation changes the expression of distinct gene families. Physiological Genomics, 7(2), 115-26 (2001)
194. W. Oriyanhan, H. Tsuneyoshi, T. Nishina, S. Matsuoka, T. Ikeda and M. Komeda: Determination of optimal duration of mechanical unloading for failing hearts to achieve bridge to recovery in a rat heterotopic heart transplantation model. Journal of Heart & Lung Transplantation, 26(1), 16-23 (2007) (Pubitemid 46096745)
195. P. Razeghi, M. Buksinska-Lisik, N. Palanichamy, S. Stepkowski, O. H. Frazier and H. Taegtmeyer: Transcriptional regulators of ribosomal biogenesis are increased in the unloaded heart. FASEB Journal, 20(8), 1090-6 (2006) (Pubitemid 44943905)
196. P. Razeghi, S. Sharma, J. Ying, Y. P. Li, S. Stepkowski, M. B. Reid and H. Taegtmeyer: Atrophic remodeling of the heart in vivo simultaneously activates pathways of protein synthesis and degradation. Circulation, 108(20), 2536-41 (2003) (Pubitemid 37444418)
197. I. P. Uray, J. H. Connelly, O. H. Frazier, H. Taegtmeyer and P. J. Davies: Mechanical unloading increases caveolin expression in the failing human heart. Cardiovascular Research, 59(1), 57-66 (2003) (Pubitemid 36780949)
198. P. H. McNulty, W. X. Liu, M. C. Luba, J. A. Valenti, G. V. Letsou and J. C. Baldwin: Effect of nonworking heterotopic transplantation on rat heart glycogen metabolism. American Journal of Physiology, 268(1 Pt 1), E48-54 (1995)
199. K. Gottlob, N. Majewski, S. Kennedy, E. Kandel, R. B. Robey and N. Hay: Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes & Development, 15(11), 1406-18 (2001) (Pubitemid 32524647)
200. S. H. Lee, N. Doliba, M. Osbakken, M. Oz and D. Mancini: Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failure. Journal of Thoracic & Cardiovascular Surgery, 116(2), 344-9 (1998) (Pubitemid 28367103)
201. O. Asghar, A. Al-Sunni, K. Khavandi, A. Khavandi, S. Withers, A. Greenstein, A. M. Heagerty and R. A. Malik: Diabetic cardiomyopathy. Clinical Science, 116(10), 741-60 (2009)
202. Z. Y. Fang, J. B. Prins and T. H. Marwick: Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocrine Reviews, 25(4), 543-67 (2004) (Pubitemid 39096070)
203. D. L. Severson: Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes. Canadian Journal of Physiology & Pharmacology, 82(10), 813-23 (2004) (Pubitemid 40223218)
204. S. Ghosh and B. Rodrigues: Cardiac cell death in early diabetes and its modulation by dietary fatty acids. Biochimica et Biophysica Acta, 1761(10), 1148-62 (2006) (Pubitemid 44512170)
205. I. G. Poornima, P. Parikh and R. P. Shannon: Diabetic cardiomyopathy: the search for a unifying hypothesis. Circulation Research, 98(5), 596-605 (2006)
206. R. Harmancey and H. Taegtmeyer: The complexities of diabetic cardiomyopathy: lessons from patients and animal models. Current Diabetes Reports, 8(3), 243-8 (2008)
207. D. An and B. Rodrigues: Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. American Journal of Physiology - Heart & Circulatory Physiology, 291(4), H1489-506 (2006) (Pubitemid 44497651)
208. D. Feuvray and A. Darmellah: Diabetes-related metabolic perturbations in cardiac myocyte. Diabetes & Metabolism, 34 Suppl 1, S3-9 (2008)
209. A. Avogaro, S. Vigili de Kreutzenberg, C. Negut, A. Tiengo and R. Scognamiglio: Diabetic cardiomyopathy: a metabolic perspective. American Journal of Cardiology, 93(8A), 13A-16A (2004) (Pubitemid 38496365)
210. X. Han, J. Yang, K. Yang, Z. Zhao, D. R. Abendschein and R. W. Gross: Alterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: a shotgun lipidomics study. Biochemistry, 46(21), 6417-28 (2007) (Pubitemid 46842885)
211. M. Yoshimura, R. Anzawa and S. Mochizuki: Cardiac metabolism in diabetes mellitus. Current Pharmaceutical Design, 14(25), 2521-6 (2008)
212. A. Guha, R. Harmancey and H. Taegtmeyer: Nonischemic heart failure in diabetes mellitus. Current Opinion in Cardiology, 23(3), 241-8 (2008) (Pubitemid 351489327)
213. Y. D. Chen, A. Golay, A. L. Swislocki and G. M. Reaven: Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus. Journal of Clinical Endocrinology & Metabolism, 64(1), 17-21 (1987) (Pubitemid 17015871)
214. B. Lewis, M. Mancini, M. Mattock, A. Chait and T. R. Fraser: Plasma triglyceride and fatty acid metabolism in diabetes mellitus. European Journal of Clinical Investigation, 2(6), 445-53 (1972)
215. G. M. Reaven, C. Hollenbeck, C. Y. Jeng, M. S. Wu and Y. D. Chen: Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes, 37(8), 1020-4 (1988) (Pubitemid 19033579)
216. E. A. Nikkila: Plasma triglycerides in human diabetes. Proceedings of the Royal Society of Medicine, 67(7), 662-5 (1974)
217. B. V. Howard, J. S. Reitman, B. Vasquez and L. Zech: Very-low-density lipoprotein triglyceride metabolism in non-insulin-dependent diabetes mellitus. Relationship to plasma insulin and free fatty acids. Diabetes, 32(3), 271-6 (1983) (Pubitemid 13138272)
218. D. Ballantyne, C. White, E. A. Strevens, T. D. Lawrie, A. R. Lorimer, W. G. Manderson and H. G. Morgan: Lipoprotein concentrations in untreated adult onset diabetes mellitus and the relationship of the fasting plasma triglyceride concentration to insulin secretion. Clinica Chimica Acta, 78(2), 323-9 (1977) (Pubitemid 8137765)
219. B. V. Howard, W. G. Abbott, W. F. Beltz, I. T. Harper, R. M. Fields, S. M. Grundy and M. R. Taskinen: Integrated study of low density lipoprotein metabolism and very low density lipoprotein metabolism in non-insulindependent diabetes. Metabolism: Clinical & Experimental, 36(9), 870-7 (1987) (Pubitemid 17136045)
220. B. V. Howard: Lipoprotein metabolism in diabetes. Current Opinion in Lipidology, 5(3), 216-20 (1994) (Pubitemid 24198818)
221. J. E. Braun and D. L. Severson: Regulation of the synthesis, processing and translocation of lipoprotein lipase. Biochemical Journal, 287(Pt 2), 337-47 (1992)
222. P. O'Looney, D. Irwin, P. Briscoe and G. V. Vahouny: Lipoprotein composition as a component in the lipoprotein clearance defect in experimental diabetes. Journal of Biological Chemistry, 260(1), 428-32 (1985) (Pubitemid 15164068)
223. L. Zhang, W. Keung, V. Samokhvalov, W. Wang and G. D. Lopaschuk: Role of fatty acid uptake and fatty acid beta-oxidation in mediating insulin resistance in heart and skeletal muscle. Biochimica et Biophysica Acta, 1801(1), 1-22 (2010)
224. A. Barsotti, A. Giannoni, P. Di Napoli and M. Emdin: Energy metabolism in the normal and in the diabetic heart. Current Pharmaceutical Design, 15(8), 836-40 (2009)
225. L. Bertrand, S. Horman, C. Beauloye and J. L. Vanoverschelde: Insulin signalling in the heart. Cardiovascular Research, 79(2), 238-48 (2008) (Pubitemid 351951609)
226. A. D. Hafstad, G. H. Solevag, D. L. Severson, T. S. Larsen and E. Aasum: Perfused hearts from Type 2 diabetic (db/db) mice show metabolic responsiveness to insulin. [see comment]. American Journal of Physiology - Heart & Circulatory Physiology, 290(5), H1763-9 (2006)
227. N. D. Oakes, P. Thalen, E. Aasum, A. Edgley, T. Larsen, S. M. Furler, B. Ljung and D. Severson: Cardiac metabolism in mice: tracer method developments and in vivo application revealing profound metabolic inflexibility in diabetes. American Journal of Physiology - Endocrinology & Metabolism, 290(5), E870-81 (2006)
228. T. S. Larsen and E. Aasum: Metabolic (in) flexibility of the diabetic heart. Cardiovascular Drugs & Therapy, 22(2), 91-5 (2008)
229. A. N. Carley and D. L. Severson: Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochimica et Biophysica Acta, 1734(2), 112-26 (2005) (Pubitemid 40724778)
230. E. Aasum, A. D. Hafstad, D. L. Severson and T. S. Larsen: Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. Diabetes, 52(2), 434-41 (2003) (Pubitemid 36173200)
231. O. J. How, E. Aasum, D. L. Severson, W. Y. Chan, M. F. Essop and T. S. Larsen: Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice. Diabetes, 55(2), 466-73 (2006) (Pubitemid 43343277)
232. P. K. Mazumder, B. T. O'Neill, M. W. Roberts, J. Buchanan, U. J. Yun, R. C. Cooksey, S. Boudina and E. D. Abel: Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes, 53(9), 2366-74 (2004) (Pubitemid 39145591)
233. J. Buchanan, P. K. Mazumder, P. Hu, G. Chakrabarti, M. W. Roberts, U. J. Yun, R. C. Cooksey, S. E. Litwin and E. D. Abel: Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology, 146(12), 5341-9 (2005) (Pubitemid 41653047)
234. S. Sharma, J. V. Adrogue, L. Golfman, I. Uray, J. Lemm, K. Youker, G. P. Noon, O. H. Frazier and H. Taegtmeyer: Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB Journal, 18(14), 1692-700 (2004) (Pubitemid 39463708)
235. M. E. Young, P. H. Guthrie, P. Razeghi, B. Leighton, S. Abbasi, S. Patil, K. A. Youker and H. Taegtmeyer: Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. Diabetes, 51(8), 2587-95 (2002) (Pubitemid 34827411)
236. O. J. How, T. S. Larsen, A. D. Hafstad, A. Khalid, E. S. Myhre, A. J. Murray, N. T. Boardman, M. Cole, K. Clarke, D. L. Severson and E. Aasum: Rosiglitazone treatment improves cardiac efficiency in hearts from diabetic mice. Archives of Physiology & Biochemistry, 113(4-5), 211-20 (2007)
237. C. Korvald, O. P. Elvenes and T. Myrmel: Myocardial substrate metabolism influences left ventricular energetics in vivo. American Journal of Physiology - Heart & Circulatory Physiology, 278(4), H1345-51 (2000) (Pubitemid 30235514)
238. A. J. Gilde and M. Van Bilsen: Peroxisome proliferator-activated receptors (PPARS): regulators of gene expression in heart and skeletal muscle. Acta Physiologica Scandinavica, 178(4), 425-34 (2003) (Pubitemid 36960434)
239. A. J. Gilde, K. A. van der Lee, P. H. Willemsen, G. Chinetti, F. R. van der Leij, G. J. van der Vusse, B. Staels and M. van Bilsen: Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.[see comment]. Circulation Research, 92(5), 518-24 (2003) (Pubitemid 36368664)
240. C. H. Lee, P. Olson and R. M. Evans: Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology, 144(6), 2201-7 (2003) (Pubitemid 36629867)
241. G. A. Francis, J. S. Annicotte and J. Auwerx: PPARalpha effects on the heart and other vascular tissues. American Journal of Physiology - Heart & Circulatory Physiology, 285(1), H1-9 (2003) (Pubitemid 36736408)
242. G. A. Francis, E. Fayard, F. Picard and J. Auwerx: Nuclear receptors and the control of metabolism. Annual Review of Physiology, 65, 261-311 (2003) (Pubitemid 38249155)
243. J. G. Duncan, J. L. Fong, D. M. Medeiros, B. N. Finck and D. P. Kelly: Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway. Circulation, 115(7), 909-17 (2007) (Pubitemid 46294731)
244. B. N. Finck, J. J. Lehman, T. C. Leone, M. J. Welch, M. J. Bennett, A. Kovacs, X. Han, R. W. Gross, R. Kozak, G. D. Lopaschuk and D. P. Kelly: The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. Journal of Clinical Investigation, 109(1), 121-30 (2002) (Pubitemid 34052548)
245. C. R. Malloy, A. D. Sherry and F. M. Jeffrey: Evaluation of carbon flux and substrate selection through alternate pathways involving the citric acid cycle of the heart by 13C NMR spectroscopy. Journal of Biological Chemistry, 263(15), 6964-71 (1988)
246. G. Vincent, B. Bouchard, M. Khairallah and C. Des Rosiers: Differential modulation of citrate synthesis and release by fatty acids in perfused working rat hearts. American Journal of Physiology - Heart & Circulatory Physiology, 286(1), H257-66 (2004) (Pubitemid 38049488)
247. S. Soyal, F. Krempler, H. Oberkofler and W. Patsch: PGC-1alpha: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes.[erratum appears in Diabetologia. 2006 Sep;49(9):2225]. Diabetologia, 49(7), 1477-88 (2006) (Pubitemid 43848083)
248. C. Canto and J. Auwerx: PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Current Opinion in Lipidology, 20(2), 98-105 (2009)
249. H. Liang and W. F. Ward: PGC-1alpha: a key regulator of energy metabolism. Advances in Physiology Education, 30(4), 145-51 (2006) (Pubitemid 44749372)
250. P. Puigserver and B. M. Spiegelman: Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocrine Reviews, 24(1), 78-90 (2003) (Pubitemid 36223280)
251. E. H. Jeninga, K. Schoonjans and J. Auwerx: Reversible acetylation of PGC-1: connecting energy sensors and effectors to guarantee metabolic flexibility. Oncogene, 29(33), 4617-24 (2010)
252. V. K. Murthy and J. C. Shipp: Accumulation of myocardial triglycerides in ketotic diabetes; evidence for increased biosynthesis. Diabetes, 26(3), 222-9 (1977) (Pubitemid 8184846)
253. V. K. Murthy and J. C. Shipp: Heart triglyceride synthesis in diabetes: selective increase in activity of enzymes of phosphatidate synthesis. Journal of Molecular & Cellular Cardiology, 12(3), 299-309 (1980) (Pubitemid 10130400)
254. M. Saddik and G. D. Lopaschuk: Triacylglycerol turnover in isolated working hearts of acutely diabetic rats. Canadian Journal of Physiology & Pharmacology, 72(10), 1110-9 (1994)
255. D. J. Paulson and M. F. Crass, 3rd: Endogenous triacylglycerol metabolism in diabetic heart. American Journal of Physiology, 242(6), H1084-94 (1982) (Pubitemid 12099283)
256. H. Yagyu, G. Chen, M. Yokoyama, K. Hirata, A. Augustus, Y. Kako, T. Seo, Y. Hu, E. P. Lutz, M. Merkel, A. Bensadoun, S. Homma and I. J. Goldberg: Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy. Journal of Clinical Investigation, 111(3), 419-26 (2003) (Pubitemid 36182219)
257. B. N. Finck, X. Han, M. Courtois, F. Aimond, J. M. Nerbonne, A. Kovacs, R. W. Gross and D. P. Kelly: A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proceedings of the National Academy of Sciences of the United States of America, 100(3), 1226-31 (2003) (Pubitemid 36183984)
258. R. H. Unger: Lipotoxic diseases. Annual Review of Medicine, 53, 319-36 (2002) (Pubitemid 34177884)
259. R. H. Unger, G. O. Clark, P. E. Scherer and L. Orci: Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochimica et Biophysica Acta, 1801(3), 209-14 (2010)
260. M. Saddik and G. D. Lopaschuk: Myocardial triglyceride turnover during reperfusion of isolated rat hearts subjected to a transient period of global ischemia. Journal of Biological Chemistry, 267(6), 3825-31 (1992)
261. H. Tuunanen, E. Engblom, A. Naum, K. Nagren, B. Hesse, K. E. J. Airaksinen, P. Nuutila, P. Iozzo, H. Ukkonen, L. H. Opie and J. Knuuti: Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure. Circulation, 114(20), 2130-7 (2006) (Pubitemid 44747893)
262. M. Yokoyama, H. Yagyu, Y. Hu, T. Seo, K. Hirata, S. Homma and I. J. Goldberg: Apolipoprotein B production reduces lipotoxic cardiomyopathy: studies in heart-specific lipoprotein lipase transgenic mouse. Journal of Biological Chemistry, 279(6), 4204-11 (2004) (Pubitemid 38199007)
263. G. D. Lopaschuk, C. A. Hansen and J. R. Neely: Fatty acid metabolism in hearts containing elevated levels of CoA. American Journal of Physiology, 250(3 Pt 2), H351-9 (1986)
264. G. D. Lopaschuk and H. Tsang: Metabolism of palmitate in isolated working hearts from spontaneously diabetic "BB" Wistar rats. Circulation Research, 61(6), 853-8 (1987) (Pubitemid 18004581)
265. D. K. Reibel, B. W. Wyse, D. A. Berkich and J. R. Neely: Regulation of coenzyme A synthesis in heart muscle: effects of diabetes and fasting. American Journal of Physiology, 240(4), H606-11 (1981) (Pubitemid 11150324)
266. P. Jezek, M. Jaburek and K. D. Garlid: Channel character of uncoupling protein-mediated transport. FEBS Letters, 584(10), 2135-41 (2010)
267. K. D. Garlid, M. Jaburek, P. Jezek and M. Varecha: How do uncoupling proteins uncouple? Biochimica et Biophysica Acta, 1459(2-3), 383-9 (2000) (Pubitemid 30612411)
268. P. Jezek, H. Engstova, M. Zackova, A. E. Vercesi, A. D. Costa, P. Arruda and K. D. Garlid: Fatty acid cycling mechanism and mitochondrial uncoupling proteins. Biochimica et Biophysica Acta, 1365(1-2), 319-27 (1998) (Pubitemid 29359274)
269. T. S. Park, Y. Hu, H. L. Noh, K. Drosatos, K. Okajima, J. Buchanan, J. Tuinei, S. Homma, X. C. Jiang, E. D. Abel and I. J. Goldberg: Ceramide is a cardiotoxin in lipotoxic cardiomyopathy.[see comment]. Journal of Lipid Research, 49(10), 2101-12 (2008)
270. Y. T. Zhou, P. Grayburn, A. Karim, M. Shimabukuro, M. Higa, D. Baetens, L. Orci and R. H. Unger: Lipotoxic heart disease in obese rats: implications for human obesity. Proceedings of the National Academy of Sciences of the United States of America, 97(4), 1784-9 (2000) (Pubitemid 30118520)
271. R. H. Unger and L. Orci: Lipoapoptosis: its mechanism and its diseases. Biochimica et Biophysica Acta, 1585(2-3), 202-12 (2002) (Pubitemid 36092084)
272. D. J. Paulson: The diabetic heart is more sensitive to ischemic injury. Cardiovascular Research, 34(1), 104-12 (1997) (Pubitemid 27261918)
273. L. M. King, R. J. Sidell, J. R. Wilding, G. K. Radda and K. Clarke: Free fatty acids, but not ketone bodies, protect diabetic rat hearts during low-flow ischemia. American Journal of Physiology - Heart & Circulatory Physiology, 280(3), H1173-81 (2001)
274. Y.-G. Niu and R. D. Evans: Metabolism of very-lowdensity lipoprotein and chylomicrons by streptozotocininduced diabetic rat heart: effects of diabetes and lipoprotein preference. American Journal of Physiology - Endocrinology & Metabolism, 295(5), E1106-16 (2008)
275. Y.-G. Niu and R. D. Evans: Myocardial metabolism of triacylglycerol-rich lipoproteins in type 2 diabetes. Journal of Physiology, 587(Pt 13), 3301-15 (2009)
276. E. J. Blanchette-Mackie, H. Masuno, N. K. Dwyer, T. Olivecrona and R. O. Scow: Lipoprotein lipase in myocytes and capillary endothelium of heart: immunocytochemical study. Am J Physiol, 256, E818-28 (1989)
277. T. Pulinilkunnil, A. Abrahani, J. Varghese, N. Chan, I. Tang, S. Ghosh, J. Kulpa, M. Allard, R. Brownsey and B. Rodrigues: Evidence for rapid "metabolic switching" through lipoprotein lipase occupation of endothelialbinding sites. Journal of Molecular & Cellular Cardiology, 35(9), 1093-103 (2003) (Pubitemid 37083253)
278. D. An, T. Pulinilkunnil, D. Qi, S. Ghosh, A. Abrahani and B. Rodrigues: The metabolic "switch" AMPK regulates cardiac heparin-releasable lipoprotein lipase. American Journal of Physiology - Endocrinology & Metabolism, 288(1), E246-53 (2005) (Pubitemid 40023814)
279. R. Rauramaa, P. Kuusela and E. Hietanen: Adipose, muscle and lung tissue lipoprotein lipase activities in young streptozotocin treated rats. Hormone & Metabolic Research, 12(11), 591-5 (1980) (Pubitemid 11196230)
280. A. Cryer and H. M. Jones: The distribution of lipoprotein lipase (clearing factor lipase) activity in the adiposal, muscular and lung tissues of ten animal species. Comparative Biochemistry & Physiology - B: Comparative Biochemistry, 63(4), 501-5 (1979) (Pubitemid 9258020)
281. T. Ruge, M. Svensson, J. W. Eriksson and G. Olivecrona: Tissue-specific regulation of lipoprotein lipase in humans: effects of fasting. European Journal of Clinical Investigation, 35(3), 194-200 (2005) (Pubitemid 40343885)
282. B. Rodrigues, M. C. Cam, K. Jian, F. Lim, N. Sambandam and G. Shepherd: Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity. Diabetes, 46(8), 1346-53 (1997) (Pubitemid 27315285)
283. C. Linder, S. S. Chernick, T. R. Fleck and R. O. Scow: Lipoprotein lipase and uptake of chylomicron triglyceride by skeletal muscle of rats. American Journal of Physiology, 231(3), 860-4 (1976)
284. K. Tavangar, Y. Murata, M. E. Pedersen, J. F. Goers, A. R. Hoffman and F. B. Kraemer: Regulation of lipoprotein lipase in the diabetic rat. Journal of Clinical Investigation, 90(5), 1672-8 (1992)
285. B. Rodrigues and D. L. Severson: Acute diabetes does not reduce heparin-releasable lipoprotein lipase activity in perfused hearts from Wistar-Kyoto rats. Canadian Journal of Physiology & Pharmacology, 71(9), 657-61 (1993) (Pubitemid 24025079)
286. K. Kobayashi, T. M. Forte, S. Taniguchi, B. Y. Ishida, K. Oka and L. Chan: The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding. Metabolism: Clinical & Experimental, 49(1), 22-31 (2000) (Pubitemid 30054029)
287. Y. Deshaies, A. Geloen, A. Paulin and L. J. Bukowiecki: Restoration of lipoprotein lipase activity in insulin-deficient rats by insulin infusion is tissue-specific. Canadian Journal of Physiology & Pharmacology, 69(6), 746-51 (1991)
288. E. Levy and M. Bendayan: Lipoprotein lipase in experimental diabetic rats: beneficial effect of vanadate treatment. Diabete et Metabolisme, 17(1), 44-8 (1991)
289. P. O'Looney, M. Vander Maten and G. V. Vahouny: Insulin-mediated modifications of myocardial lipoprotein lipase and lipoprotein metabolism. Journal of Biological Chemistry, 258(21), 12994-3001 (1983) (Pubitemid 14237282)
290. L. Liu and D. L. Severson: Endothelial binding sites for lipoprotein lipase are not diminished in perfused hearts from diabetic rats.[erratum appears in Can J Physiol Pharmacol 1998 Feb;76(2):242]. Canadian Journal of Physiology & Pharmacology, 74(11), 1204-9 (1996) (Pubitemid 27079776)
291. J. E. Braun and D. L. Severson: Diabetes reduces heparin-and phospholipase C-releasable lipoprotein lipase from cardiomyocytes. American Journal of Physiology, 260(3 Pt 1), E477-85 (1991)
292. A. Boivin and Y. Deshaies: Contribution of hyperinsulinemia to modulation of lipoprotein lipase activity in the obese Zucker rat. Metabolism: Clinical & Experimental, 49(1), 134-40 (2000) (Pubitemid 30054046)
293. P. Pillutla, Y. C. Hwang, A. Augustus, M. Yokoyama, H. Yagyu, T. P. Johnston, M. Kaneko, R. Ramasamy and I. J. Goldberg: Perfusion of hearts with triglyceride-rich particles reproduces the metabolic abnormalities in lipotoxic cardiomyopathy. American Journal of Physiology - Endocrinology & Metabolism, 288(6), E1229-35 (2005) (Pubitemid 40726811)
294. S. Levak-Frank, W. Hofmann, P. H. Weinstock, H. Radner, W. Sattler, J. L. Breslow and R. Zechner: Induced mutant mouse lines that express lipoprotein lipase in cardiac muscle, but not in skeletal muscle and adipose tissue, have normal plasma triglyceride and high-density lipoprotein-cholesterol levels. Proceedings of the National Academy of Sciences of the United States of America, 96(6), 3165-70 (1999) (Pubitemid 29148862)
295. A. N. Carley, L. L. Atkinson, A. Bonen, M.-E. Harper, S. Kunnathu, G. D. Lopaschuk and D. L. Severson: Mechanisms responsible for enhanced fatty acid utilization by perfused hearts from type 2 diabetic db/db mice. Archives of Physiology and Biochemistry, 113(2), 65-75 (2007) (Pubitemid 46904760)
296. A. N. Carley and D. L. Severson: What are the biochemical mechanisms responsible for enhanced fatty acid utilization by perfused hearts from type 2 diabetic db/db mice? Cardiovascular Drugs & Therapy, 22(2), 83-9 (2008)
297. G. H. Tomkin and D. Owens: Abnormalities in apo Bcontaining lipoproteins in diabetes and atherosclerosis. Diabetes/Metabolism Research Reviews, 17(1), 27-43 (2001) (Pubitemid 32203869)
298. J. McEneny, M. J. O'Kane, K. W. Moles, C. McMaster, D. McMaster, C. Mercer, E. R. Trimble and I. S. Young: Very low density lipoprotein subfractions in Type II diabetes mellitus: alterations in composition and susceptibility to oxidation. Diabetologia, 43(4), 485-93 (2000) (Pubitemid 30237958)
299. J. G. Duncan, K. G. Bharadwaj, J. L. Fong, R. Mitra, N. Sambandam, M. R. Courtois, K. J. Lavine, I. J. Goldberg and D. P. Kelly: Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators. Circulation, 121(3), 426-35 (2010)
300. R. Carroll and D. L. Severson: Peroxisome proliferator-activated receptor-alpha ligands inhibit cardiac lipoprotein lipase activity. American Journal of Physiology - Heart & Circulatory Physiology, 281(2), H888-94 (2001)
301. R. K. Vikramadithyan, K. Hirata, H. Yagyu, Y. Hu, A. Augustus, S. Homma and I. J. Goldberg: Peroxisome proliferator-activated receptor agonists modulate heart function in transgenic mice with lipotoxic cardiomyopathy. Journal of Pharmacology & Experimental Therapeutics, 313(2), 586-93 (2005) (Pubitemid 40604158)
302. M. S. Kim, G. Kewalramani, P. Puthanveetil, V. Lee, U. Kumar, D. An, A. Abrahani and B. Rodrigues: Acute diabetes moderates trafficking of cardiac lipoprotein lipase through p38 mitogen-activated protein kinase-dependent actin cytoskeleton organization. Diabetes, 57(1), 64-76 (2008)
303. D. Hauton: Does long-term metformin treatment increase cardiac lipoprotein lipase? Metabolism: Clinical & Experimental, 60(1), 32-42 (2011)
304. M. Ohira, Y. Miyashita, T. Murano, F. Watanabe and K. Shirai: Metformin promotes induction of lipoprotein lipase in skeletal muscle through activation of adenosine monophosphate-activated protein kinase. Metabolism: Clinical & Experimental, 58(10), 1408-14 (2009)
305. M. L. Brown, M. P. Ramprasad, P. K. Umeda, A. Tanaka, Y. Kobayashi, T. Watanabe, H. Shimoyamada, W. L. Kuo, R. Li, R. Song, W. A. Bradley and S. H. Gianturco: A macrophage receptor for apolipoprotein B48: cloning, expression, and atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America, 97(13), 7488-93 (2000) (Pubitemid 30431490)
306. S. S. Jain, A. Chabowski, L. A. Snook, R. W. Schwenk, J. F. Glatz, J. J. Luiken and A. Bonen: Additive effects of insulin and muscle contraction on fatty acid transport and fatty acid transporters, FAT/CD36, FABPpm, FATP1, 4 and 6. FEBS Letters, 583(13), 2294-300 (2009)
307. R. Zechner: The tissue-specific expression of lipoprotein lipase: implications for energy and lipoprotein metabolism. Current Opinion in Lipidology, 8(2), 77-88 (1997) (Pubitemid 27235067)
308. M. Merkel, Y. Kako, H. Radner, I. S. Cho, R. Ramasamy, J. D. Brunzell, I. J. Goldberg and J. L. Breslow: Catalytically inactive lipoprotein lipase expression in muscle of transgenic mice increases very low density lipoprotein uptake: direct evidence that lipoprotein lipase bridging occurs in vivo. Proceedings of the National Academy of Sciences of the United States of America, 95(23), 13841-6 (1998) (Pubitemid 28523060)
309. T. Iwasaki, S. Takahashi, M. Takahashi, Y. Zenimaru, T. Kujiraoka, M. Ishihara, M. Nagano, J. Suzuki, I. Miyamori, H. Naiki, J. Sakai, T. Fujino, N. E. Miller, T. T. Yamamoto and H. Hattori: Deficiency of the very lowdensity lipoprotein (VLDL) receptors in streptozotocininduced diabetic rats: insulin dependency of the VLDL receptor. Endocrinology, 146(8), 3286-94 (2005) (Pubitemid 41058099)
310. H. Yagyu, E. P. Lutz, Y. Kako, S. Marks, Y. Hu, S. Y. Choi, A. Bensadoun and I. J. Goldberg: Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency. Journal of Biological Chemistry, 277(12), 10037-43 (2002) (Pubitemid 34968113)
311. J. C. Obunike, E. P. Lutz, Z. Li, L. Paka, T. Katopodis, D. K. Strickland, K. F. Kozarsky, S. Pillarisetti and I. J. Goldberg: Transcytosis of lipoprotein lipase across cultured endothelial cells requires both heparan sulfate proteoglycans and the very low density lipoprotein receptor. Journal of Biological Chemistry, 276(12), 8934-41 (2001)
312. X. Yu, S. C. Burgess, H. Ge, K. K. Wong, R. H. Nassem, D. J. Garry, A. D. Sherry, C. R. Malloy, J. P. Berger and C. Li: Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart. Proceedings of the National Academy of Sciences of the United States of America, 102(5), 1767-72 (2005) (Pubitemid 40209242)
313. D. Ricart-Jane, P. Cejudo-Martin, J. Peinado-Onsurbe, M. D. Lopez-Tejero and M. Llobera: Changes in lipoprotein lipase modulate tissue energy supply during stress. Journal of Applied Physiology, 99(4), 1343-51 (2005) (Pubitemid 43014338)
314. G. Kewalramani, P. Puthanveetil, M. S. Kim, F. Wang, V. Lee, N. Hau, E. Beheshti, N. Ng, A. Abrahani and B. Rodrigues: Acute dexamethasone-induced increase in cardiac lipoprotein lipase requires activation of both Akt and stress kinases. American Journal of Physiology - Endocrinology & Metabolism, 295(1), E137-47 (2008)
315. Y. Deshaies, A. Geloen, A. Paulin, A. Marette and L. J. Bukowiecki: Tissue-specific alterations in lipoprotein lipase activity in the rat after chronic infusion of isoproterenol. Hormone & Metabolic Research, 25(1), 13-6 (1993) (Pubitemid 23035812)
316. D. L. Severson, R. Carroll, A. Kryski, Jr. and I. Ramirez: Short-term incubation of cardiac myocytes with isoprenaline has no effect on heparin-releasable or cellular lipoprotein lipase activity. Biochemical Journal, 248(1), 289-92 (1987) (Pubitemid 17161047)
317. R. Carroll, A. N. Carley, J. R. Dyck and D. L. Severson: Metabolic effects of insulin on cardiomyocytes from control and diabetic db/db mouse hearts. American Journal of Physiology - Endocrinology & Metabolism, 288(5), E900-6 (2005) (Pubitemid 40547883)
318. T. Utriainen, T. Takala, M. Luotolahti, T. Ronnemaa, H. Laine, U. Ruotsalainen, M. Haaparanta, P. Nuutila and H. Yki-Jarvinen: Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM. Diabetologia, 41(5), 555-9 (1998) (Pubitemid 28206826)
319. J. C. Chatham and A. M. Seymour: Cardiac carbohydrate metabolism in Zucker diabetic fatty rats. Cardiovascular Research, 55(1), 104-12 (2002) (Pubitemid 34615944)
320. D. D. Belke, T. S. Larsen, E. M. Gibbs and D. L. Severson: Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. American Journal of Physiology - Endocrinology & Metabolism, 279(5), E1104-13 (2000)
321. M. Panagia, J. E. Schneider, B. Brown, M. A. Cole and K. Clarke: Abnormal function and glucose metabolism in the type-2 diabetic db/db mouse heart. Canadian Journal of Physiology & Pharmacology, 85(3-4), 289-94 (2007) (Pubitemid 47262232)
322. M. Panagia, G. F. Gibbons, G. K. Radda and K. Clarke: PPAR-alpha activation required for decreased glucose uptake and increased susceptibility to injury during ischemia. American Journal of Physiology - Heart & Circulatory Physiology, 288(6), H2677-83 (2005) (Pubitemid 40720645)